Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/CE

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/CE History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/CE(x) 5.613.982.981.181.16

What is the latest EV/CE ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/CE ratio of GLENMARK PHARMACEUTICALS is 5.61 based on Mar2026 Consolidated results.
Year EV/CE
Mar20265.61
Mar20253.98
Mar20242.98
Mar20231.18
Mar20221.16

How is EV/CE of GLENMARK PHARMACEUTICALS Trending?

Years EV/CE % Change
Mar2026 5.61
40.95
Mar2025 3.98
33.56
Mar2024 2.98
152.54
Mar2023 1.18
1.72
Mar2022 1.16 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/CE ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,837.3 Cr 5.4% -3.5% 22.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,991.0 Cr 0.2% -5.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹256,310.0 Cr 4.9% -0.5% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,604.0 Cr -1.1% -8.5% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,722.0 Cr 7.8% 11% 1.2% Stock Analytics
CIPLA ₹109,628.0 Cr 2.3% -2.7% -18.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5.4%

-3.5%

22.3%

SENSEX

1.2%

0.4%

-12.2%


You may also like the below Video Courses